CAMG
ANVS icon

CWA Asset Management Group’s Annovis Bio ANVS Stock Holding History

CWA Asset Management Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.1K Buy
28,001
+11,000
+65% +$21.4K ﹤0.01% 697
2026
Q1 		$37.9K Hold
17,001
– – ﹤0.01% 655
2025
Q4 		$58.8K Buy
17,001
+4,000
+31% +$12K ﹤0.01% 633
2025
Q3 		$26.9K Sell
13,001
-6,000
-32% -$15K ﹤0.01% 655
2025
Q2 		$41.2K Buy
+19,001
New +$37.5K ﹤0.01% 632

Other funds holding ANVS

FNT
First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $102M AUM
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
QWM
Quadcap Wealth Management Frisco, Texas $1.03B AUM 28.22% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

CWA Asset Management Group's ANVS Position: Q2 2026 in Review

CWA Asset Management Group increased its Annovis Bio (ANVS) stake by 65% in Q2 2026, buying an estimated $21.4K and bringing the position to 28,001 shares worth $52.1K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

CWA Asset Management Group first reported a position in ANVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $58.8K in Q4 2025. 13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • CWA Asset Management Group held 28,001 shares of Annovis Bio worth $52.1K as of Q2 2026.
  • CWA Asset Management Group bought 11,000 Annovis Bio shares in Q2 2026, an estimated $21.4K.
  • Annovis Bio made up ﹤0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #697 holding.
  • CWA Asset Management Group first reported a position in Annovis Bio in Q2 2025 and has held it in 5 quarters since.
  • CWA Asset Management Group's Annovis Bio position peaked at $58.8K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.